Heart Failure Clinical Trial

Balance, Aerobic Capacity, Mobility and Strength in Patients Hospitalized for Heart Failure (BAMS-HF) Program

Summary

This is a pilot randomized trial of the BAMS-HF (Balance, Aerobic capacity, Mobility and Strength in patients hospitalized for Heart Failure) Program versus usual care. The BAMS-HF Program pilot study is an initial step in eventually creating a comprehensive, patient-centered, primarily home-based rehabilitation intervention aimed at preventing worsening disability and dependence among older adults hospitalized for HF. The BAMS-HF Program will enroll patients hospitalized for HF (or with HF as an active problem during hospitalization) within the past 4 weeks and will engage patients during the vulnerable post-discharged period. The objective of this pilot study is to test the feasibility, acceptability and preliminary effect of the BAMS-HF Program in older (>/= 65 years) adults hospitalized for HF. The BAMS-HF Program will begin within 4 week of hospital discharge and be administered 3 times weekly for 12 weeks in the patient's home upon discharge. Patients who are able to safely complete the program without in-person assistance will transition to telehealth (aka telerehabilitation) visits. The BAMS-HF Program is innovative because it is home-based, and will utilize rigorous, progressive exercises across multiple domains of physical function. The estimated preliminary effect size will be measured with the Short Physical Performance Battery (SPPB), a well-validated measure that predicts incident mobility/disability and falls in the geriatric population.

Aim #1: To assess the feasibility of the BAMS-HF Program by measuring 1) study enrollment rate, 2) proportion of prescribed sessions that were actually performed, 3) proportion of patients completing full baseline assessment and outcome measures

Aim #2: To assess the acceptability of the BAMS-HF Program with qualitative interviews of participants in the intervention arm that will ask about their experience in the program, any aspects of the intervention they recommend changing and whether patients would recommend the program to others. Reason for declining or stopping participation in the study will also be recorded and considered in adjusting the study protocol.

Aim #3: To estimate the preliminary intervention effect by investigating the difference in change in SPPB between the BAMS-HF Program arm and the usual care arm.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

55 years old or older
Hospitalized for HF or with HF as an active problem during hospitalization
SPPB >/=10

Exclusion Criteria:

Irreversible orthopedic or neurologic disease that severely limits mobility
Active cancer diagnosis except non-melanoma skin cancer
Dementia
Life expectancy of < 6 months
Uncontrolled/untreated ventricular tachycardia or ventricular fibrillation
Advanced heart failure with expectation of left ventricular assist device or transplant in the next 6 months
Any major surgery in the past 30 days or planned in the next 10 weeks
Discharge to a skilled nursing facility and/or home with home healthcare physical therapy (home health care nurse or occupational therapist is ok)

Study is for people with:

Heart Failure

Estimated Enrollment:

29

Study ID:

NCT04281849

Recruitment Status:

Completed

Sponsor:

VA Eastern Colorado Health Care System

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Rocky Mountain Regional VA Medical Center
Aurora Colorado, 80045, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

29

Study ID:

NCT04281849

Recruitment Status:

Completed

Sponsor:


VA Eastern Colorado Health Care System

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.